XML 20 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows (unaudited) - USD ($)
 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (15,077,551) $ (21,485,683)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 205,924 257,115
Decrease in right-of-use asset 271,458 260,832
Unrealized foreign currency transaction loss (gain) 15,900 (68,653)
Stock-based compensation 1,045,669 1,330,502
Change in fair value of liability classified warrants 0 6,962,562
Gain on sale of Vyleesi (2,500,000) (7,798,280)
Gain on purchase commitment (416,000) 0
Changes in operating assets and liabilities:    
Accounts receivable 0 2,915,760
Other receivables (271,037) 0
Prepaid expenses and other assets (199,906) 1,206,564
Inventories 0 (1,154,355)
Accounts payable 3,668,638 (860,280)
Accrued expenses (3,678,586) (4,171,297)
Operating lease liabilities (282,104) (264,875)
Other liabilities 0 (2,118,897)
Net cash used in operating activities (17,217,595) (24,988,985)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Maturity of marketable securities 0 2,992,890
Proceeds from sale of Vyleesi 2,500,000 9,500,000
Purchases of property and equipment 0 (37,615)
Net cash provided by investing activities 2,500,000 12,455,275
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payment of withholding taxes related to restricted stock units (99,482) (56,401)
Proceeds from the sale of common stock and warrants, net 4,457,520 14,693,779
Payment of finance lease obligations (46,014) (79,265)
Proceeds from exercise of warrants 3,398,237 103
Net cash provided by financing activities 7,710,261 14,558,216
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (7,007,334) 2,024,506
CASH AND CASH EQUIVALENTS, beginning of period 9,527,396 7,989,582
CASH AND CASH EQUIVALENTS, end of period 2,520,062 10,014,088
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid for interest 11,538 13,741
Conversion of liability classified warrants   11,423,203
Conversion of liability classified warrants upon warrant exercise $ 0 $ 2,389,903